الفا-1 اينٽي ٽرپسن جو گهٽ نتيجو هڪ اسڪريننگ اشارو آهي، جينياتي تشخيص ناهي. ايندڙ قدم عام طور تي فينوٽائپ يا جينوٽائپ تصديق آهي، ان کان پوء سوچي سمجهي نه ته بي ترتيب خاندان جي جانچ ڪئي وڃي.
هي گائيڊ هيٺين جي قيادت ۾ لکيو ويو: ڊاڪٽر ٿامس ڪلين، ايم ڊي جي تعاون سان ڪينٽيسٽي اي آءِ ميڊيڪل ايڊوائزري بورڊ, ، جنهن ۾ پروفيسر ڊاڪٽر هانس ويبر جا تعاون ۽ ڊاڪٽر سارہ مچل، ايم ڊي، پي ايڇ ڊي جو طبي جائزو شامل آهي.
ٿامس ڪلين، ايم ڊي
چيف ميڊيڪل آفيسر، ڪينٽيسٽي اي آءِ
ڊاڪٽر ٿامس ڪلين هڪ بورڊ-سرٽيفائيڊ ڪلينڪل هيماتولوجسٽ ۽ انٽرنسٽ آهن، جن کي ليبارٽري ميڊيسن ۽ AI-مدد يافته ڪلينڪل تجزيي ۾ 15 سالن کان وڌيڪ جو تجربو آهي. Kantesti AI ۾ چيف ميڊيڪل آفيسر جي حيثيت ۾، هو ملڪيت واري نيورل نيٽ ورڪ جي طبي درستگيءَ جي ڪلينڪل نگراني فراهم ڪن ٿا. ڊاڪٽر ڪلين بائيو مارڪر جي تشريح ۽ ليبارٽري ڊائگنوسٽڪس تي شايع ڪري چڪا آهن.
سارہ مچل، ايم ڊي، پي ايڇ ڊي
چيف ميڊيڪل ايڊوائيزر - ڪلينڪل پيٿالوجي ۽ اندروني دوائون
ڊاڪٽر سارا مچل هڪ بورڊ-سرٽيفائيڊ ڪلينڪل پيتھولوجسٽ آهن، جن کي ليبارٽري ميڊيسن ۽ ڊائگنوسٽڪ تجزئي ۾ 18 سالن کان وڌيڪ جو تجربو آهي. انهن وٽ ڪلينڪل ڪيمسٽري ۾ خاص سرٽيفڪيشنون آهن ۽ ڪلينڪل مشق ۾ بائيو مارڪر پينلز ۽ ليبارٽري تجزئي بابت ڪيترائي تحقيقي ڪم شايع ڪيا آهن.
پروفيسر ڊاڪٽر هانس ويبر، پي ايڇ ڊي
ليبارٽري ميڊيسن ۽ ڪلينڪل بايو ڪيمسٽري جو پروفيسر
پروف. ڊاڪٽر هانس ويبر کي ڪلينڪل بايو ڪيمسٽري، ليبارٽري ميڊيسن، ۽ بائيو مارڪر ريسرچ ۾ 30+ سالن جو ماهرانه تجربو آهي. جرمن سوسائٽي فار ڪلينڪل ڪيمسٽري جا اڳوڻا صدر، هو ڊائگنوسٽڪ پينل تجزئي، بائيو مارڪر معياري ڪرڻ، ۽ AI-مدد ٿيل ليبارٽري ميڊيسن ۾ ماهر آهن.
- حفاظتي حد تقريباً 11 µmol/L آهي، جيڪو اڪثر نيپيلوميٽري ذريعي 57 mg/dL طور ٻڌايو ويندو آهي؛ ان کان هيٺيون قدر سخت گهٽتائي جي خدشات کي وڌائين ٿيون.
- گهٽ AAT سطح اڪيلو ورثي ۾ گهٽتائي کي عارضي ليبارٽري اثر، جگر جي بيماري، پروٽين جي نقصان، يا ايسي جي فرق کان ممتاز نٿو ڪري سگهي.
- Pi*MZ ڪيريئر جي حيثيت عام طور تي عام AAT ڪنسنٽريشن جو 80% پيدا ڪري ٿو ۽ سگريٽ جي تماڪ يا وڏي پيشه ورانه مٽي جي نمائش سان گڏ هجڻ وقت سڀ کان اهم هوندو آهي.
- Pi*ZZ گهٽتائي عام طور تي 20-45 mg/dL جي آس پاس AAT ڪنسنٽريشن پيدا ڪري ٿو ۽ ڦڦهن ۽ جگر جي اهم خطري سان گڏ هوندو آهي.
- AAT جينوٽائپ ٽيسٽ عام S ۽ Z ويرينٽس لاءِ مفيد آهي، پر جڏهن ليول ۽ جينوٽائپ متفق نه هجن ته فينٽائپنگ يا جين سڪوئننگ جي ضرورت پئجي سگهي ٿي.
- اڪيوت-فيس اثر انفيڪشن، زخمي، حمل، يا فعال سوزش دوران AAT کي تقريباً 75% کان 100% تائين وڌائي سگھي ٿو ۽ کوٽائي کي لڪائي سگھي ٿو.
- خاندان جي جاچ عام طور تي جينياتي صلاح مشوري کان پوءِ تصديق ٿيل ڪيريئر يا متاثر ٿيل شخص جي والدين، ڀائرن، ٻارن ۽ ساٿين کي پيش ڪيو ويندو آهي.
- تماڪ کان پاسو شديد AAT جي کوٽائي يا خطرناڪ جينوٽائپ وارن ماڻهن لاءِ سڀ کان وڌيڪ طاقتور ڦڦسن جي حفاظت جو طريقو آهي.
الفا-1 اينٽي ٽرپسن جو گهٽ نتيجو اصل ۾ ڇا مطلب آهي
گهٽ الفا-1 اينٽيٽريپسن ليولس گهٽتائي پروٽين جي سرگرمي جي نشاني آهي، نه ته توهان کي شديد موروثي کوٽائي آهي ان جو ثبوت. تقريباً 11 µmol/L کان گهٽ ڪنسنٽريشن - يا ڪيترين ئي نيوفيلوميٽرڪ ايسيز تي لڳ ڀڳ 57 mg/dL - تصديقي ٽيسٽ جي لائق آهي ڇو ته اهو ڪيميائي حد کان هيٺ آهي جنهن هيٺ ڦڦسن جي ٽشوز کي گهٽ اينٽي پروٽيز تحفظ ملي ٿو.
الفا-1 اينٽيٽريپسن، يا AAT, ، جگر ۾ ٺهيل آهي ۽ ڦڦسن تائين گردش ڪري ٿو، جتي اهو نيٽروفل ايلاسيٽيز کي متوازن ڪري ٿو. عملي طور تي، تمام گهٽ AAT الويولر ٽشوز کي ڏهاڪن تائين نقصان جي وڌيڪ حساس بڻائي ٿو، خاص طور تي تمباکو جي نمائش سان. جگر جي انزيمز کي ان سان گڏ پڙهڻ گهرجي؛ اسان جي گائيڊ جگر جي ٽيسٽ جي مخففات بيان ڪري ٿو ته ALT, AST, بليروبين ۽ البومين ڪيئن مفيد حوالي سان شامل ڪيا وڃن ٿا.
ليبارٽري ريفرنس انٽروال حفاظتي حد کان مختلف آهي. ڪيتريون ئي ليبارٽريون بالغن لاءِ تقريباً 100–190 mg/dL، يا 20–37 µmol/L، لسٽ ڪن ٿيون، جيتوڻيڪ 85 mg/dL جو نتيجو صرف معمولي گهٽ هجي ۽ خود بخود PiZZ کوٽائي جي معنيٰ نٿو رکي. مون صحتمند PiMZ ڪيريئرز کي هن وچ واري زون ۾ ڏٺو آهي، جڏهن ته نمونيا دوران ٽيسٽ ڪيل ماڻهوءَ جو ظاهري طور تي اطمينان بخش نتيجو ٿي سگهي ٿو ڇو ته AAT اڪيوت-فيس ريڪٽنٽ طور ڪم ڪري ٿو.
ڊاڪٽر ٿامس ڪلين جو ڪلينڪل اصول سادو آهي: گهٽ ڪنسنٽريشن کي رستو شروع ڪرڻ سمجھو. ان کي ٻيهر ورجايو يا جينوٽائپ ۽/يا فينٽائپ ٽيسٽنگ سان تصديق ڪريو، جڏهن سوزش ممڪن هجي ته سي-ريڪٽيو پروٽين چيڪ ڪريو، ۽ ڦڦسن جي علامتن، تمباکو جي تاريخ، جگر جي ڪيمسٽري، ۽ گڏيل خانداني تاريخ جو جائزو وٺو.
حد ايسي-مخصوص ڇو آهي
اڪثر ڏنل 11 µmol/L حد مختلف طريقن سان مختلف ٿئي ٿي: نيوفيلوميٽري ذريعي تقريباً 57 mg/dL، پر پراڻي ريڊيل inmunodiffusion ڪيليبريشن سان 80 mg/dL جي ويجھو. ليبارٽري جو بيان ڪيل طريقو ۽ يونٽس هر نتيجي سان گڏ هجڻ گهرجن؛ انهن کان سواءِ هڪ سادي اسڪرين شاٽ هڪ تجربا ڪندڙ ڪلينڪ کي به گمراهه ڪري سگهي ٿو.
الفا-1 اينٽي ٽرپسن ٽيسٽ رينج ۽ حفاظتي ڪٽ آف
گهڻا بالغن جا AAT ڪنسنٽريشن 100–190 mg/dL جي ويجھو هوندا آهن، پر ڪلينڪل طور تي مفيد سوال اهو آهي ته نتيجو ايسي-مخصوص حفاظتي حد کان مٿي آهي يا هيٺ. نيوفيلوميٽري ذريعي 57 mg/dL کان گهٽ قدر شديد کوٽائي جو مضبوطي سان اشارو ڏين ٿا ۽ ان کي معمولي ننڍي حد کان ٻاهر وارو نشان نه سمجهيو وڃي.
AAT عام طور تي سيرم ۾ immunonephelometry يا immunoturbidimetry ذريعي ماپيو ويندو آهي. اهي طريقا پروٽين جي ڪنسنٽريشن جو اندازو لڳائين ٿا، جينياتي سڃاڻپ نه، جيڪو سبب آهي ته ليول مؤثر طريقي سان اسڪرين ڪري سگهي ٿي پر مڪمل جواب نه ڏئي سگهي. فرق ان ڳالهه جي برابر آهي ته معیاری ۽ مقداري جانچ: هڪ نتيجو ٻڌائي ٿو ته ڪيترو موجود آهي، جڏهن ته ٻيو سڃاڻي سگهي ٿو ته ڪهڙي صورت موجود آهي.
57–90 mg/dL کان نتيجا اڪثر تشخيصي خاڪي زون ۾ اچي ويندا آهن. PiSZ, PiMZ، نادر تبديليون، ۽ گهٽ بيس لائن گڏيل عام تجزياتي تبديلي سان هتي اوورليپ ڪري سگهن ٿيون؛ معمول جي اموناسيز لاءِ تبديلي جو اختيار عام طور تي ڪجهه سيڪڙو هوندو آهي. ڪلينڪل طور تي مستحڪم هجڻ دوران هڪ ٻي ٽيسٽ ڪرڻ هڪ حد تائين قيمت مان جينوٽائپ جو اندازو لڳائڻ جي ڪوشش ڪرڻ کان وڌيڪ مفيد آهي.
120 mg/dL کان مٿي نتيجو مڪمل طور تي ڪيريئر جي حالت کي خارج نٿو ڪري، ڇاڪاڻ ته سوزش AAT کي خاص طور تي وڌائي سگهي ٿي. هڪ ڪلينڪ ۾، مون هڪ MZ ڪيريئر جو جائزو ورتو جنهن جي سطح 154 mg/dL هئي سوزش واري گٿريٽس جي flare دوران ۽ 103 mg/dL ٽي مهينا بعد - ٻئي ان لئب جي انٽرويل ۾، پر حياتياتي طور تي تمام مختلف.
ڇو ته گهٽ سطح ۽ ڪيريئر جي حيثيت هڪجهڙي تشخيص نه آهي
ڪيريئر جي حيثيت SERPINA1 جي موروثي تبديلين کي بيان ڪري ٿي، جڏهن ته AAT جي سطح هڪ ڏينهن هڪ نموني ۾ ماپيل پروٽين کي بيان ڪري ٿي. هڪ شخص هڪ تبديل ٿيل اليل سان گهٽ-عام نتيجي سان گڏ کڻي سگهي ٿو، ۽ ٻئي ۾ وراثت ۾ مليل کوٽ جي سببن کان سواء گهٽ AAT هجي.
عام عام جينوٽائپ آهي PiMM. PiMZ جو مطلب عام طور تي هڪ M ۽ هڪ Z اليل هوندو آهي، اڪثر سراسري جي 60% جي برابر AAT سان؛ PiSZ گهٽ سطحون پيدا ڪرڻ جي رجحان رکي ٿو، اڪثر 40% جي برابر؛ PiZZ عام طور تي 10%–20% پيدا ڪري ٿو. اهي سيڪڙو آبادي جي سراسري آهن، ذاتي پيشنگوئيون نه آهن—انفرادي قدر اڪثر ليبارٽري رپورٽن جي ڀيٽ ۾ وڌيڪ اوورليپ ڪندا آهن.
Pi*MZ وارو ماڻهو ڪيريئر هوندو آهي، پر هر ڪيريئر کي ڦڦڙن يا جگر جي بيماري ناهي ٿيندي. سگريٽ نوشي او ب اسٽرڪٽو لنگ ڊيزيز لاءِ اهم موڊيفائر آهي، ۽ معدني مٽي، دونھون، يا بائيوماس جي دونھين جي نمائش سان پريشاني وڌي ٿي. COPD فائونڊيشن گائيڊ لائن COPD وارن سڀني ماڻهن، غير جوابي دمہ، اڻ ڄاتل برونڪيڪٽيسس، يا اڻ ڄاتل جگر جي بيماري (Sandhaus et al., 2016) جي آزمائش جي سفارش ڪري ٿي.
Kantesti AI هڪ اي آءِ بلڊ ٽيسٽ اينالائيزر جيڪو هڪ گهٽ AAT نتيجو inflammatory markers، liver chemistry، ۽ pulmonary clues جي اڳيان رکي ٿو، ان جي بدران صرف هڪ ڪنسنٽريشن مان جينياتي ليبل پيش ڪرڻ جي. اسان جو بائومارڪر گائيڊ پڻ مريضن کي سندن طبيب لاءِ اصل يونٽس ۽ ليبارٽري طريقو محفوظ ڪرڻ ۾ مدد ڪري ٿو.
هڪ غلط فهمي جيڪا مان اڪثر درست ڪريان ٿو
“ڪيريئر” جو مطلب “ڳالهائڻ لاءِ ڪجهه به ناهي” ناهي. ان جو مطلب آهي ته روڪٿام جي گفتگو تبديل ٿي وڃي: سگريٽ نوشي کان مڪمل طور تي بچو، ڪم جي جڳهه جي نمائش کي جلدي خطاب ڪريو، ۽ نتيجي کي دستاويز ڪريو ته جيئن نئون تنفسي طبيب جينياتي طور تي گهٽ AAT کي عارضي ليبارٽري انوملي سمجهي نه سگهي.
ڇو AAT ڪنسنٽريشن ڪوڙي طور تي اطمينان بخش يا غير متوقع طور تي گهٽ ٿي سگهي ٿي
سوزش، حمل، انفيڪشن، ۽ ٽشوز جي زخم AAT کي وراثت ۾ مليل گهٽتائي کي لڪائڻ لاءِ ڪافي وڌائي سگهن ٿا، جڏهن ته پروٽين جو نقصان ۽ جگر جي شديد خرابي ان کي گهٽ ڪري سگهي ٿي. C-reactive protein جي ماپ ۽ ڪلينڪل سيٽنگ جو جائزو ڪوڙن نتيجن جو هڪ حيران ڪندڙ تعداد روڪي ٿو.
AAT هڪ اڪثر-فيس پروٽين آهي ۽ بيڪٽيريل انفيڪشن، فعال آٽو imun بيماري، صدمي، يا دير سان حمل دوران تقريبن 75%–100% تائين وڌي سگهي ٿو. جيڪڏهن CRP وڌايو ويو آهي، هڪ عام AAT ڪنسنٽريشن ان کان گهٽ اطمينان بخش آهي جيئن اهو ڏسڻ ۾ اچي ٿو. اهو هڪ سبب آهي جو نتيجو گهٽ ۾ گهٽ ڪيترن ئي هفتن کان پوءِ بحال ٿيڻ کان پوءِ ورجايو وڃي جڏهن تاريخ ۽ پهريون نتيجو نه ملي.
گهٽ البومين، نيفرٽيڪ-رينج پيشاب پروٽين جو نقصان، شديد malnutrition، يا جگر جي پروٽين جي synthesis جي ترقي يافته خرابي گڏيل ڪيترائي سيرم پروٽين گهٽائي سگهن ٿا. هڪ گهٽ AAT گڏيل گهٽ البومين ۽ ڊگھو INR صرف AAT جي گهٽتائي کان مختلف ڪلينڪل مسئلو ڏانهن اشارو ڪري ٿو؛ سيرم پروٽين گائيڊ هن نموني لاءِ مفيد پس منظر آهي.
Assay interference غير معمولي پر حقيقي آهي. تمام گهڻو lipaemic نمونا، نموني جو مکس اپ، ۽ مختلف ٺاهيندڙن جي ڪيليبريشن هڪ فيصلي جي حد جي ويجهو تضاد پيدا ڪري سگهن ٿا. عددي نتيجي، يونٽ، حوالي جي حد، نموني جي تاريخ، ۽ ڇا ليبارٽري reflex phenotype يا genotyping ڪيو آهي ان لاءِ پڇو—“غير معمولي” اڪيلو ڪلينڪل طور تي قابل استعمال نتيجو نه آهي.
جڏهن جينوٽائپ، فينوٽائپ، يا ترتيب نتيجي جي تصديق ڪرڻ گهرجي
AAT genotype ٽيسٽ عام وراثت ۾ ملندڙ متغيرن جي سڃاڻپ ڪري ٿي، phenotype ٽيسٽ circulating protein patterns جي سڃاڻپ ڪري ٿي، ۽ sequencing غير معمولي يا متضاد ڪيسن کي حل ڪري ٿو. گهٽ سطح لاءِ، ڪلينڪ عام طور تي صرف ڪنسنٽريشن تي ڀروسو ڪرڻ جي بدران گهٽ ۾ گهٽ ٻن طريقن جو استعمال ڪندا آهن.
Targeted genotyping عام طور تي پهريان S ۽ س ۽ Z SERPINA1 alleles جي ڳولا ڪري ٿو. اهو تيز ۽ مفيد آهي، پر اهو null alleles ۽ ڪيترائي نادر متغير مس ڪري سگهي ٿو؛ “S ۽ Z لاءِ نفي” جو نتيجو “وراثت ۾ مليل گهٽتائي نه” جي برابر ناهي جيڪڏهن AAT واضح طور تي گهٽ آهي. 2003 ATS/ERS بيان خاص طور تي genotyping پلس AAT جي ماپ جي حمايت ڪري ٿو، جتي نتيجا متضاد آهن (ATS/ERS، 2003).
Phenotyping AAT پروٽين جي حرڪت جي نموني کي ڏيکارڻ لاءِ isoelectric focusing استعمال ڪري ٿو. اهو M، S، Z ۽ ڪيترن ئي ٻين پروٽين متغيرن جي سڃاڻپ ڪري سگهي ٿو، پر null alleles ڪو به پروٽين نه ٺاهيندا آهن ۽ phenotype پاران اڪيلو مس ٿي سگهن ٿا. Sequencing خاص طور تي قيمتي آهي جڏهن تمام گهٽ سطح MM-جهڙي phenotype يا عام-متغير genotyping سان متضاد هجي.
جڏهن مان 38 mg/dL جي AAT ۽ صرف هڪ Z allele جي رپورٽ سان گڏ هڪ پينل جو جائزو وٺان ٿو، مان ان کي “بس MZ” نه سڏيندو آهيان. مان پڇندو آهيان ته ڇا ٻيو نادر يا null allele هجي ها. جگر جي تشخيص اڪثر ڪري پوءِ ٿيندي آهي، جنهن ۾ FIB-4 calculation عمر، AST، ALT، ۽ platelets مان، جيتوڻيڪ FIB-4 کي اڪيلو AATD تشخيصي اوزار طور تصديق نه ڪيو ويو آهي.
جينوٽائپ ڦڦهن جي خطري کي ڪيئن تبديل ڪري ٿو - ۽ ڇو تماڪ ان کي وڌيڪ تبديل ڪري ٿو
PiZZ ۽ null genotypes emphysema جي سڀ کان وڌيڪ خطري ۾ شامل آهن، جڏهن ته PiMZ ماڻهن ۾ و vulnerability وڌائي ٿو جيڪي سگريٽ نوشي ڪن ٿا. AAT سان لاڳاپيل emphysema ۾ اڪثر basal-predominant panacinar خصوصيتون هونديون آهن، پر صرف تصويري نمونو genotype جو تشخيص نٿو ڪري سگهي.
شديد AAT جي کوٽ سانس جي تڪليف، وائي، دائمي کنگهه، بار بار سينه جي انفيڪشن، يا گهٽجي ويل ورزش جي برداشت سان پيش ٿي سگهي ٿي - ڪڏهن ڪڏهن 45 سالن کان گهٽ عمر ۾، جيتوڻيڪ بعد ۾ پيشڪش عام آهي. Spirometry رڪاوٽ ڏيکاري سگهي ٿو، پر عام spirometry نتيجو شروعاتي بيماري کي رد نٿو ڪري. بنيادي spirometry bronchodilator test ۽ diffusion capacity سان عام طور تي تصديق ٿيل شديد کوٽ کان پوء معقول آهي.
سگريٽ نوشي صرف genotype جي ڀيٽ ۾ گهڻو تيزيء سان گهٽتائي کي وڌائي ٿي. منهنجي تجربي ۾، سڀ کان وڌيڪ روڪڻ لائق الميو اهو ماڻهو آهي جيڪو سگريٽ نوشي جي سالن کان پوءِ ئي Pi*ZZ جي حيثيت بابت سکي ٿو ڇاڪاڻ ته ڪنهن به انهن کي جانچ نه ڪئي جڏهن “دم” دم وانگر ڪم نه ڪري رهيو هو. Strnad ۽ ساٿي AAT جي کوٽ کي ڦڦڙن ۽ جگر جي بيماري جي طور تي بيان ڪن ٿا جنهن ۾ انتهائي متغير اظهار آهي، نمائش ۽ genotype (Strnad et al., 2020) جي شڪل ۾.
سينه جو CT هر ڪيريئر لاءِ معمول جو اسڪريننگ ٽيسٽ نٿو آهي. اهو سمجهيو ويندو آهي جڏهن علامتون، spirometry، diffusion capacity، يا تشخيصي سوال تابڪاري جي نمائش کي جواز ڏئي ٿو؛ سانس جي تڪليف وارا مريض پڻ اسان جو استعمال ڪري سگهن ٿا ساهه کڻڻ ۾ تڪليف لاء رت جي ٽيسٽ جو رهنمائي غير جينياتي سببن کي سمجهڻ لاءِ جيڪي ڪلينيڪل عام طور تي پهرين چيڪ ڪندا آهن.
جگر جو خطرو: ڇو رت جي سطح ان کي صحيح نموني سان پيش نه ڪري ٿي
AAT جي کوٽ ۾ جگر جي نقصان جو سبب hepatocytes جي اندر Z پروٽين جي غير معمولي رڪاوٽ مان نڪرندو آهي، تنهنڪري گهٽ سيرم AAT سطح جگر جي وڌيڪ خطري سان برابر نٿو ٿئي. PiZZ واضح وراثت وارو خطرو کڻندو آهي، جڏهن ته PiMZ الڪوحل، موهپ، وائرل هيپاٽائٽس، يا مٽي جي جگر جي بيماري کان خطري کي تبديل ڪري سگهي ٿو.
تصديق ٿيل شديد کوٽ وارا بالغن کي عام طور تي جگر تي ڌيان ڏيڻ جي ضرورت آهي: ALT، AST، alkaline phosphatase، GGT، bilirubin، albumin، platelet count، ۽ hepatomegaly يا splenomegaly جي جانچ. جگر جي عام انزائمز fibrosis کي رد نٿا ڪن، ۽ هڪ واحد هلڪي وڌايل ALT غير مخصوص آهي. مفيد سوال اهو آهي ته ڇا غير معمولي شيون جاري رهيون يا cholestatic، hepatocellular، يا synthetic-function pattern ٺاهي ڇڏين.
Pi*MZ کي هڪ خطري جي تبديل ڪندڙ جي طور تي وڌيڪ تسليم ڪيو پيو وڃي بجاءِ خودڪار جگر جي بيماري جي تشخيص جي. مون کي پريشان ڪندڙ مجموعو MZ پلس metabolic dysfunction-associated steatotic liver disease، مسلسل وڌايل ALT، گهٽجندڙ platelets، يا الڪوحل جي نمائش آهي - اڪيلو MZ ناهي. بابت وڌيڪ پڙهو MASLD ليبارٽري جو جائزو جيڪڏهن metabolic خطرو تصوير جو حصو آهي.
پيلي، نئين پيٽ جي سوجن، الٽي واري رت، مونجهارو، ڪارا پاخانا، يا اونداهي پيشاب سان جلدي وڌندڙ خارش جي صورت ۾ فوري تشخيص ضروري آهي. سست تبديلين لاءِ، رجحان ڊيٽا اهم آهن: 6-12 مهينن کان وڌيڪ ورجايون قدر هڪ اهڙي رفتار ڏيکاري سگهن ٿيون جيڪا هڪ “عام” پينل نٿو ڪري سگهي.
الفا-1 اينٽي ٽرپسن جي جانچ مان ڪهڙا مائٽ فائدو حاصل ڪري سگهن ٿا
تصديق ٿيل غير معمولي SERPINA1 genotype واري ماڻهوءَ جي والدين، ڀائرن، ٻارن ۽ ٻارن جي ساٿي کي جينياتي مشاورت ۽ جانچ پيش ڪئي وڃي. صرف AAT سطح ذريعي مائٽن جي جانچ خاندان جي بنياد تي genotype جي جانچ کان گهٽ ڀروسي لائق آهي ڇاڪاڻ ته ڪيريئر جي سطحون حوالي جي دائري سان اوورليپ ڪن ٿيون.
هڪ تصديق ٿيل PiZZ نتيجو جو مطلب آهي ته هر والدين گهٽ ۾ گهٽ هڪ ڪيريئر آهي، ۽ هر ٻار هڪ تبديل ٿيل ٻٻر وارث ٿو. هڪ PiMZ نتيجو جو مطلب آهي ته پهرين درجي جا مائٽ MZ، ZZ، يا ٻين مجموعن جا ڪيريئر ٿي سگهن ٿا، ٻئي والدين جي genotype تي منحصر ڪري. خاندان جي جانچ باخبر روڪٿام ۽ توليدي وضاحت بابت آهي، الزام نه؛ جين خاندان جي درجه بندي يا سٺي نيت جي پيروي نٿا ڪن.
COPD فائونڊيشن گائيڊلائن غير معمولي جين جي سڃاڻپ کان پوءِ بالغن جي ڀائرن، والدين، ٻارن ۽ وڌايل خاندان کي جانچ پيش ڪرڻ جي سفارش ڪري ٿي، جانچ کان اڳ ۽ پوءِ مشاورت سان (Sandhaus et al., 2016). ٻارن تي غور ڪري سگهجي ٿو جڏهن نتيجو طبي سنڀال يا گهرو سگريٽ نوشي جي نمائش کي متاثر ڪندو، مثالي طور تي ٻارن جي ڪلينيڪل يا جينياتي پيشه ور ذريعي جيڪو خاندان جي حوالي کي سمجهي ٿو.
Kantesti AI خاندان جي خطري جي ڳالهه ٻولهه کي الڳ، رضامندي سان ليبارٽري جي تاريخن کي منظم ڪندي سپورٽ ڪري ٿو، بجاءِ اهو سمجهڻ جي ته هڪ مائٽ جو ڊيٽا ٻئي جو آهي. اسان جي خاندان جي صحت رڪارڊ گائيڊ انھن عملي تفصيلن جي وضاحت ڪري ٿو جن کي محفوظ ڪرڻ لائق آھي: صحيح جينوٽائپ، ايسي طريقو، بيس لائن ڦڦڙن جي جاچ، جگر جي رجحانات، ۽ نمائش.
ورثي ۾ مليل AAT خطري بابت غير ضروري خوف پيدا ڪرڻ کان سواء ڪيئن گفتگو ڪجي
خاندان جو واضح پيغام اهو آهي: هڪ تصديق ٿيل نتيجو روڪٿام کي متاثر ڪري سگهي ٿو، پر اهو اهو پيش نه ڪندو آهي ته خاندان جو هر فرد بيمار ٿيندو. صحيح جينوٽائپ ۽ ليبارٽري رپورٽ شيئر ڪريو، علامتن مان اندازو لڳائڻ کان پاسو ڪريو، ۽ جنياتي صلاح جي رستي جي آڇ ڪريو.
هڪ مختصر حقيقت واري نوٽ سان شروع ڪريو: “مون SERPINA1 جينوٽائپ X جي تصديق ڪئي آهي؛ منهنجي ڪلينڪ خاندان جي ويجھن ميمبرن کي جاچ تي غور ڪرڻ جي صلاح ڏني.” ليبارٽري جو نالو ۽ تاريخ شامل ڪريو، پر اجازت کان سواء ٻئي شخص جي طبي پورٽل جي تصوير نه وٺو. 10 منٽن جي فون ڪال اڪثر ڪري هڪ صوفائي گروپ پيغام کان وڌيڪ مهربان آهي جيڪو “جنياتي ڦڦڙن جي بيماري” جو اعلان ڪري ٿو.”
خاندان جا ميمبر روزگار، انشورنس، بدنامي، ۽ توليدي فيصلن بابت معقول سوال پڇي سگهن ٿا. اهي جواب ملڪ جي لحاظ کان مختلف هوندا آهن، تنهنڪري مقامي جنياتي صلاحڪار سماجي-ميڊيا جي اطمينان کان وڌيڪ مفيد آهي. گھڻن مريضن لاء صحت جو انتظام ھدايت رضامندي تي ٻڌل طريقن جو خاڪو پيش ڪري ٿو جن سان خاندان جي نتيجن کي الڳ رکي سگهجي ٿو جڏهن ته وارثي جو درست رڪارڊ برقرار رکي.
ڊاڪٽر ٿامس ڪلين ڊگهي مائٽن جي ٽيسٽنگ جي خلاف مشورو ڏئي ٿو ته متاثر شخص جي جينوٽائپ کي پهرين واضح ڪرڻ کان سواء. جيڪڏهن پهرين شخص وٽ صرف گهٽ AAT ڪنسنٽريشن آهي ۽ ڪا به تصديق واري ٽيسٽ ناهي، خاندان هڪ اڻ ڄاتل بائيو ڪيميڪل نتيجي جو تعاقب ڪري رهيو هوندو نه ته هڪ متعين موروثي تبديلي.
گهٽ AAT نتيجي کان پوء هڪ عملي ايندڙ قدم جو منصوبو
گهٽ AAT نتيجي کان پوء، ايسي ۽ يونٽن جي تصديق ڪريو، سوزش جو اندازو لڳايو، جينوٽائپ يا فينٽائپ ٽيسٽنگ جو حڪم ڏيو، ۽ ڦڦڙن ۽ جگر جي حالت جو جائزو وٺو. گهڻن ماڻهن کي ايمرجنسي علاج جي ضرورت ناهي، پر تصديق ٿيل سخت گھٽتائي کي وساريل چارٽ نوٽ جي بدران منظم فالو اپ ڪرڻ گهرجي.
قدم پهريون تصديق آهي: اصل نتيجو حاصل ڪريو ۽ اهو طئي ڪريو ته اهو سرم (serum) هو يا پلازما، نيوفيلوميٽري يا ٻيو طريقو، ۽ ڇا CRP وڌايو ويو هو. قدم ٻيو S/Z جينوٽائپنگ پلس فينٽائپ سان تصديق آهي، يا سيكوئنسنگ جڏهن فينٽائپ، جينوٽائپ، ۽ سطح گڏ نه ٿين. هي تسلسل هر ڪجهه هفتن ۾ بي ترتيب AAT سطحن کي ورجائڻ کان وڌيڪ معلوماتي آهي.
قدم ٽيون بيس لائن اندازو آهي جيڪو نتيجي مطابق تيار ڪيو ويو آهي. تصديق ٿيل سخت گھٽتائي عام طور تي اسپروميٽري، برونڪوڊيليٽر جواب، جتي موجود هجي اتي ڊفيوژن جي گنجائش، جگر جي ڪيمسٽري، پلاٽليٽ ڳڻپ، ۽ تماڪ، ويپنگ، بايوماس جي نمائش، ۽ ڪم جي جڳهه جي جلن تي صلاح مشوري جو سبب بڻجي ٿي. ويڪسينشن ۽ معمول جي تنفسي سنڀال سنسڪرت رهي ٿي، پر ڪا به سپليمينٽ نه آهي جيڪا گم ٿيل AAT کي تبديل ڪري.
Kantesti AI هڪ AI ليب ٽيسٽ جي تشريح واري سروس جيڪو هڪ طبي ملاقات کان اڳ اصل AAT نتيجي، CRP، جگر جي پينل، ۽ سيريل قدرن کي منظم ڪرڻ ۾ مدد ڪري سگهي ٿو؛ اهو ليبارٽري ۽ ڪلينر پاران تشخيصي تصديق جو متبادل ناهي. ڪا به رپورٽ شيئر ڪرڻ کان اڳ، اسان جي PDF اپلوڊ پرائيويسي چيڪ لسٽ ۽ انهن شناختن کي هٽايو جن کي توهان برقرار رکڻ جي ضرورت ناهي.
جڏهن augmentation therapy تي غور ڪيو ويندو آهي - ۽ جڏهن نه
رگ ذريعي AAT اضافي تھراپي عام طور تي تصديق ٿيل سخت گھٽتائي لاء سمجھي ويندي آهي جنھن ۾ قائم ايئر فلو رڪاوٽ ھوندي آھي، نه صرف الڳ ٿيل گھٽ سطحن يا گهڻن ڪيئرئرز لاء. گهڻن سيٽنگن ۾ معمول جو لائسنس يافته رجيم 60 mg/kg رگ ذريعي ھفتي ۾ ھڪڙي ڀيرو آھي، جيتوڻيڪ قومي قابليت ۽ فنڊنگ جا ضابطا مختلف آھن.
اضافي رت ۾ AAT وڌائي ٿو ۽ چونڊيل ماڻهن ۾ جنھن ۾ سخت AATD-سان لاڳاپيل ايمفيسيما آھي، CT تي ڦڦڙن جي گھڻائي جي نقصان کي سست ڪرڻ لاء ثبوت آھي. اھو موجود ايمفيسيما کي ريورس نٿو ڪري، جگر جي بيماري جو علاج نٿو ڪري، يا تماڪ ڇڏڻ جو متبادل نٿو بڻجي. فيصلا عام طور تي تنفسي ماهر، دستاويزي جينوٽائپ، سرم جي سطح، اسپيروميٽري، CT حوالي سان، ۽ مقامي معيارن ۾ شامل هوندا آهن.
Pi*MZ ڪيريئرز کي معمول جي مطابق اضافي تھراپي سان علاج نه ڪيو ويندو آھي، جيتوڻيڪ سندن AAT ڪنسنٽريشن ٿوري گهٽ ھجي. اھو فرق اھم آھي ڇو ته علاج جو بار وڏو آھي: ھفتيوار انفيوژن، وينس رسائي جي لاجسٽڪس، خرچ، ۽ ڪڏهن ڪڏهن انفيوژن ردعمل. MZ سگريٽ نوشي ڪندڙ لاء سڀ کان وڌيڪ اثرائتو مداخلت مڪمل طور تي بند ڪرڻ آھي، نه ته پروٽين جي سطح جو تعاقب ڪرڻ.
ڪي مريض پڇن ٿا ته ڇا ورزش غير محفوظ آهي. عام طور تي، نه: علامات، آڪسيجنشن، ۽ پلمونري بحالي جي صلاح جي مطابق ترتيب ڏنل سپروائزڊ اييروبڪ ۽ طاقت جو ڪم مددگار آھي. جيڪڏهن ڪو ڪلينڪ اضافي جو تجويز ڏئي ٿو، پڇو ته ڪھڙو نتيجو انھن جو مقصد آھي ۽ اھي ايندڙ 12 مھينن ۾ فائدي کي ڪيئن ماپيندا.
خاص حالتون: حمل، ٻار، ۽ اڻ ڄاتل تنفس جي بيماري
حمل ۽ فعال سوزش AAT کي وڌائي سگهي ٿي ۽ گھٽتائي کي لڪائي سگهي ٿي، جڏهن ته خاندان جي تصديق ٿيل تبديلين سان گڏ ٻارن کي خودڪار بيماري جي ليبلنگ بدران عمر جي لحاظ کان مناسب صلاح مشوري جي ضرورت آهي. اڻ ڄاتل برونڪيڪٽيسس، مستقل رڪاوٽ، يا ڪنهن به عمر ۾ جگر جي بيماري الفا-1 اينٽي ٽريپسين گھٽتائي جي جانچ جو جواز پيش ڪري سگهي ٿي.
حمل دوران، AAT اڪثر ڪري معمولي اڪيوت-فيس جي رد عمل جي حصي جي طور تي وڌندي آهي، تنهنڪري هڪ معمولي ڪنسنٽريشن معلوم ٿيل متاثر خاندان ۾ ڪيريئر جي حيثيت کي يقيني طور تي خارج نٿو ڪري سگهي. جينوٽائپ حمل سان نه بدلندو آهي ۽ ڪنهن به وقت ڪيو وڃي ٿو. پرينٽل يا ريپروڊڪٽو ٽيسٽنگ کي جينياتي پروفيسرن سان بحث ڪيو وڃي ڇو ته قيمت ڄاڻايل انتخاب ۾ آهي، نه ته جلدي طبي علاج ۾.
ٻارن لاءِ، تصديق ٿيل خانداني متغير ڄاڻڻ جا فوري فائدا ۾ تمباکو کان پاڪ گهر، مستقبل ۾ تمباکو جي استعمال کان بچڻ، ۽ مسلسل جگر جي غير معموليات جي مناسب تشخيص شامل ٿي سگهي ٿي. امڪاني نقصانن ۾ پريشاني ۽ مستقبل جي رازداري جا خدشا شامل آهن، تنهنڪري وقت کي انفرادي طور تي مقرر ڪيو وڃي. هڪ عام نئون ڄاول اسڪرين عام طور تي هن سوال جو جواب نه ڏيندو آهي جيستائين اهو تصديق ٿيل SERPINA1 ٽيسٽنگ شامل نه هجي.
AAT جي کوٽ گهڻو ڪري انهن ماڻهن ۾ غائب ٿي ويندي آهي جن کي خراب جواب ڏيندڙ دمہ سان ليبل ڪيو ويو آهي. جيڪڏهن سانس وٺڻ جو آواز بالغن ۾ شروع ٿيو، ايئر فلو رڪاوٽ مقرر ٿيل آهي، يا CT هيٺئين ڦڦڙن جي ايمفيسيما جو مشورو ڏئي ٿو، پڇو ته ڇا AAT ڪڏهن چڪاس ڪيو ويو هو؛ بار بار تنفسي انفيڪشن پڻ وسيع بار بار انفيڪشن بلڊ ٽيسٽ ورڪ اپ.
ورثي ۾ مليل پروٽين جي نتيجي لاء AI تشريح کي محفوظ طور تي استعمال ڪرڻ
AI هڪ AAT نتيجي کي منظم ڪري سگهي ٿو ۽ تصديق جي ضرورت کي ظاهر ڪري سگهي ٿو، پر اهو پروٽين ڪنسنٽريشن مان نادر SERPINA1 جينوٽائپ جو تعين نٿو ڪري سگهي. محفوظ تعبير يونٽ، حوالا انٽرويل، دوا ۽ بيماري جي حوالي سان، برقرار رکي ٿو، ۽ واضح طور تي خطري جي اسڪريننگ کي تشخيص کان الڳ ڪري ٿو.
Kantesti AI هڪ AI-powered رت جي ٽيسٽ تجزيي جو اوزار جيڪو الفا-1 اينٽي ٽرپسن ٽيسٽ کي CRP، البومين، بليروبين، AST، ALT، پلیٽليٽس، ۽ اڳئين نتيجن سان گڏ تقريباً 60 سيڪنڊن ۾ جائزو وٺندو آهي. هڪ سمجھدار نتيجو گهٽ سطح لاءِ “تصديق تي غور ڪريو” چوڻ گهرجي، نه ته مريض کي چون ته هن وٽ Pi*ZZ آهي جينوٽائپ يا فينوٽائپ ثبوت کان سواء.
رجحان جو تجزيو خاص طور تي شديد بيماري کانپوءِ مفيد آهي. AAT 112 mg/dL CRP 68 mg/L سان 92 mg/dL CRP 3 mg/L کان هيٺ سان گهٽ پرسکون ٿي سگهي ٿو، اڃا تائين ڪو به قدر جينوٽائپ جو تعين نٿو ڪري. اسان پنهنجي تعبير جي منطق کي ڊيزائن ڪيو آهي ته هن عدم مطابقت کي ڪلينر جي بحث لاءِ ظاهر ڪجي؛ پڙهندڙ اسان ۾ لاڳاپيل ڪلينڪل حفاظت جو جائزو وٺي سگهن ٿا طبي توثيق جو جائزو.
سيپٽمبر 26، 2026 تائين، ڊاڪٽر ٿامس ڪلين اڃا تائين تصديق ٿيل شديد نتيجي، غير معمولي رڪاوٽ واري ڦڦڙن جي بيماري، غير معمولي جگر جي ٽيسٽ، يا جينوٽائپ-سطح خاندان جي فيصلي لاءِ ماهرن جي راءِ جي سفارش ڪري ٿو. AI ان گفتگو ۾ رستو ننڍو ڪجي، ان کي مٽائي نه.
AAT ٽيسٽ کان پوء توهان جي ڪلينشين سان گفتگو ڪرڻ لاء سوال
سڀ کان وڌيڪ مفيد سوال اهو پڇندا آهن ته ڇا توهان جي ڪنسنٽريشن، فينوٽائپ، ۽ جينوٽائپ متفق آهن، ۽ ڇا توهان جا ڦڦڙ يا جگر ڪنهن به موجوده اثر کي ڏيکارين ٿا. پورٽل پرچم يا نمبر جي يادگيري تي ڀروسو ڪرڻ جي بدران مڪمل رپورٽ آڻيو.
پڇو: “ڪهڙي طريقي سان منهنجي AAT کي ماپ ڪيو ويو، mg/dL ۽ µmol/L ۾ قدر ڇا آهي، ۽ ڇا CRP وڌايو ويو هو؟” پوءِ پڇو: “ڇا مون کي S/Z جينوٽائپنگ، فينوٽائپ ٽيسٽنگ، يا مڪمل تسلسل جي ضرورت آهي؟” اهي سوال عام ڊيڊ-اينڊ کي روڪين ٿا جنهن ۾ صرف اهو ٻڌايو وڃي ته هڪ نتيجو “گهٽ” آهي.”
جيڪڏهن شديد کوٽ جي تصديق ٿئي ٿي، ته بيس لائن اسپيروميٽري، ڊيفيوژن جي گنجائش، ويڪسينيشن، ڪم جي جڳهه جي نمائش، جگر جي نگراني، ۽ ڇا تنفسي يا جگر جي ماهر کي سنڀال جي همٿائڻ گهرجي بابت پڇو. جيڪڏهن توهان هڪ ڪيريئر آهيو، پنهنجي ذاتي خطري جي سادي لساني وضاحت لاءِ پڇو، نه ته ٻه طرفي “عام/غير معمولي” ليبل. خانداني ڊاڪٽر نتيجا شيئرنگ گائيڊ ان دوري لاءِ هڪ مختصر رڪارڊ تيار ڪرڻ ۾ توهان جي مدد ڪري سگهي ٿي.
اسان جي طبي مواد جو جائزو ڊاڪٽر جي نگراني سان ڪيو ويندو آهي، ۽ طبي صلاحڪار بورڊ وضاحت ڪري ٿو ته ڪيئن ڪلينڪل ماهر Kantesti AI جي تعليمي حدن کي ڄاڻيندي آهي. عملي مقصد اهو ناهي ته هر گهٽ نتيجي کي تشخيص ۾ تبديل ڪجي؛ اهو يقيني بڻائڻ آهي ته ڪا به اهم موروثي کوٽ غائب نه ٿئي.
گهٽ AAT سطحن ۽ خاندان جي خطري لاء بنيادي ڳالهه
گهٽ AAT ڪنسنٽريشن تصديق ڏانهن وڌڻ گهرجي، نه خوف: جينوٽائپ ۽ فينوٽائپ ٽيسٽنگ واضح ڪري ٿو ته ڇا نتيجو شديد کوٽ، ڪيريئر جي حيثيت، هڪ نادر متغير، يا غير جنيٽي اثر آهي. هڪ دفعو خانداني متغير جي تصديق ٿي وڃي، پهرين درجي جا مائٽ ٽيسٽنگ ۽ روڪٿام بابت ڄاڻيل فيصلا ڪري سگهن ٿا.
اڪيلو قدر جيڪو جلدي تبديل ڪري ٿو، ايسي-مخصوص قدر 11 µmol/L جي ويجهو يا ان کان هيٺ آهي، اڪثر ڪري 57 mg/dL نيوفيلميٽري ذريعي. ان سطح کان هيٺ، شديد کوٽ يا نل جي متغيرن جي گهڻو ڪري ممڪن آهي؛ ان کان مٿي، ڪيريئر ۽ سوزش واري ماسڪنگ اڃا تائين حوالي سان گهرجن. نتيجو CRP، جينوٽائپ، فينوٽائپ، نمائش جي تاريخ، ۽ عضوي جي تشخيص سان تعلق رکي ٿو.
گهڻا مريض محسوس ڪن ٿا ته خاندان جي گفتگو منظم ٿي ويندي آهي جڏهن انهن وٽ شيئر ڪرڻ لاءِ هڪ صحيح جملو هوندو آهي: “هي موروثي آهي، ٽيسٽنگ دستياب آهي، ۽ نتيجو تماڪ جي نمائش کي روڪي ڦڦڙن جي حفاظت ۾ مدد ڪري سگهي ٿو.” اهو رشتيدارن کي کنگهه، ٿڪاوٽ، يا آن لائن ڪيلڪوليٽر مان پاڻ کي تشخيص ڪرڻ لاءِ چوڻ کان وڌيڪ مفيد پيغام آهي.
Kantesti AI وزرن جي وچ ۾ ليبارٽري جي طولي حوالي کي برقرار رکي سگهي ٿو، جڏهن ته AI تشونڪن ٽيڪنالاجي گائيڊ وضاحت ڪري ٿو ته شروعاتي قدر ۽ غير يقيني ڪيئن محفوظ ڪيا وڃن ٿا. تصديق ٿيل AAT جي کوٽ طبي فالو اپ جي مستحق آهي؛ هڪ واحد گهٽ نتيجو پهرين احتياط سان سمجهڻ جي لائق آهي.
وچان وچان سوال ڪرڻ
الفا-1 antitrypsin جو ڪهڙو سطح گهٽ سمجهيو ويندو آهي؟
11 µmol/L کان گهٽ الفا-1 antitrypsin جو مقدار ڦڦھڙن جي بافتن لاءِ روايتي حفاظتي حد کان گهٽ سمجهيو ويندو آهي. Nephelometric assays تي، 11 µmol/L تقريباً 57 mg/dL جي برابر آهي، پر پراڻا radial immunodiffusion طريقا 80 mg/dL جي برابر حد ٻڌائي سگهن ٿا. گھڻا بالغ حوالا انٽروال 100–190 mg/dL جي لڳ ڀڳ هوندا آهن، جيتوڻيڪ هر ليبارٽري پنهنجي حد مقرر ڪري ٿي. گهٽ نتيجي جي تصديق genotype ۽/يا phenotype ٽيسٽ سان ڪئي وڃي ڇاڪاڻ ته صرف مقدار inherited variant قائم نٿو ڪري.
ڇا الفا-1 antitrypsin جي سطح معمول جي هجڻ باوجود توهان ڪيريئر ٿي سگهو ٿا؟
ها، هڪ ماڻهوءَ ۾ الفا-1 antitrypsin جي عام سطح هئڻ باوجود SERPINA1 variant، خاص ڪري Pi*MZ رکي سگهي ٿو. تيز سوزش، انفيڪشن، حمل، ۽ زخمي AAT کي تقريبن 75% کان 100% تائين وڌائي سگھن ٿا، جيڪا جنياتي طور تي گھٽ بيس لائن پيداوار کي لڪائي سگھي ٿي. S ۽ Z variants يا پروٽين phenotyping لاءِ ٽارگيٽيڊ جينوٽائپنگ، ڪيريئر اسٽيٽس جي تصديق ڪرڻ لاءِ صرف سطح کان وڌيڪ قابل اعتماد آهي. اهو خاص طور تي لاڳاپيل آهي جڏهن ويجھي رشتيدار تصديق ٿيل AAT جي گھٽتائي رکي ٿو.
ڇا Pi*MZ جو مطلب آھي ته توھان کي emphysema ٿيندو؟
PiMZ جو مطلب اهو ناهي ته emphysema ناگزير آهي. PiMZ عام طور تي AAT جي سراسري ڪنسنٽريشن جو 60% پيدا ڪري ٿو، ۽ ڪيترائي غير سگريٽ نوشي ڪندڙ ڪڏهن به ڪلينڪل طور تي اهم ڦڦڙن جي بيماري پيدا نٿا ڪن. سگريٽ جو دھواں سڀ کان وڌيڪ known known know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know know knowThe A1AT protein is made in the liver and protects the lungs from certain enzymes. However, in people with A1AT deficiency, not enough of this protein is produced, leaving the lungs unprotected. The Alpha-1 Antitrypsin test can help determine if you have Alpha-1 Antitrypsin deficiency. This test measures the level of A1AT in your blood. A low A1AT level may indicate that you have Alpha-1 Antitrypsin deficiency. If you have a low A1AT level, your doctor may recommend further testing to confirm the diagnosis. There are different types of A1AT deficiency, and the severity of the condition can vary. Some people with A1AT deficiency may not experience any symptoms, while others may develop serious lung problems, such as emphysema or chronic obstructive pulmonary disease (COPD). If you have a family history of lung disease or Alpha-1 Antitrypsin deficiency, it is important to talk to your doctor about getting tested. Early diagnosis and treatment can help manage the condition and prevent further lung damage.
ڇا الفا-1 ضد ٽرپسن جي گھٽتائيءَ ۾ مبتلا شخص جي ٻارن کي جانچڻ گھرجي؟
تصديق ٿيل غير معمولي SERPINA1 جينوٽائپ واري شخص جي ٻارن کي جاچ مان فائدو ٿي سگهي ٿو، پر وقت جو تعين هڪ ٻارن جي ماهر يا جنيٽڪس پروفيشل سان گڏ ڪيو وڃي. نتيجو مستقل طور تي تماڪ کان پاڪ گهر جي حمايت ڪري سگهي ٿو ۽ مسلسل جگر جي غيرمعمولي حالت جي تشخيص کي واضح ڪري سگهي ٿو، اڃا تائين اهو پريشاني ۽ رازداري جي خدشات پيدا ڪري سگهي ٿو. جينوٽائپ ٽيسٽ جي عمر تي ڪا به اثر ناهي، جڏهن ته AAT جو ڌيان سوزش سان مختلف ٿي سگهي ٿو. تصديق ٿيل خانداني جينوٽائپ هڪ بالغن ۾ اڪيلو گهٽ پروٽين جي نتيجي کان تمام گهڻو واضح بحث ڪري ٿو.
AAT فینوٽائپ ۽ جينوٽائپ ٽيسٽنگ ۾ ڇا فرق آهي؟
AAT فينوٽائپ ٽيسٽنگ سيرم ۾ گردش ڪندڙ AAT پروٽين جي نموني کي سڃاڻڻ لاءِ پروٽين جي ڌار ڌار ڪرڻ، عام طور تي آئسو اليڪٽرڪ فوڪسنگ، استعمال ڪندي. AAT جينوٽائپ ٽيسٽنگ SERPINA1 جين جو جائزو وٺندي آهي، عام طور تي S ۽ Z ويرئنٽ سان شروع ٿيندي. فينوٽائپنگ null ويرئنٽس کي وساري سگهي ٿي ڇاڪاڻ ته اهي ڪا به پروٽين پيدا نه ڪندا آهن، جڏهن ته محدود جينوٽائپنگ نادر ويرئنٽس کي وساري سگهي ٿي جيڪي پينل ۾ شامل نه آهن. جڏهن AAT تمام گهٽ هجي يا سطح ۽ پهرين جينياتي نتيجو متفق نه هجن، ته ان جي ترتيب جو اگھم ڀيرو ڀيرو ٽيسٽ ٿي سگهي ٿي.
ڇا الفا-1 ضد-ٽرپسن جي گھٽتائي جگر تي اثر ڪري سگهي ٿي جيتوڻيڪ ڦڦڙن جا ٽيسٽ معمول تي هجن؟
ها، الفا-1 اينٽي ٽرپسن جي گهٽتائي جگر کي ڦڦڙن جي ڪم کان الڳ طور تي متاثر ڪري سگهي ٿي. Pi*ZZ بيماري ۾، غير معمولي Z پروٽين هيپاٽو سائيٽس ۾ جمع ٿي سگهي ٿو، جڏهن ته گهٽ گردش ڪندڙ AAT بنيادي طور تي ڦڦڙن جي ڪمزوري جي وضاحت ڪري ٿو. ALT، AST، GGT، بليروبين، البومين، پليٽليٽ ڳڻپ، ۽ ڪڏهن ڪڏهن جگر جي تصوير يا ايلسٽوگرافي جگر جي حالت جو اندازو لڳائڻ لاءِ استعمال ڪيا ويندا آهن. اسپائروميٽري ۾ نارمل هجڻ جگر جي شموليت کي رد نٿو ڪري، ۽ جگر جي نارمل اينزائمز فائبروسس کي مڪمل طور تي رد نٿا ڪن.
اڄ ئي AI-طاقتور خون جي جاچ جو تجزيو حاصل ڪريو
دنيا ڀر ۾ 2 ملين کان وڌيڪ استعمال ڪندڙن ۾ شامل ٿيو جيڪي فوري ۽ درست ليب ٽيسٽ تجزيو لاءِ Kantesti تي ڀروسو ڪن ٿا. پنهنجا خون جي جاچ جا نتيجا اپلوڊ ڪريو ۽ سيڪنڊن ۾ 15,000+ بائيو مارڪرز جي جامع تشريح حاصل ڪريو.
📚 حوالا ڏنل تحقيقي اشاعتون
ڪلين، ٽي.، مچل، ايس.، ۽ ويبر، ايڇ. (2026). ڪلين، ٽي. (2026). aPTT نارمل رينج: D-Dimer، پروٽين سي بلڊ ڪلٽنگ گائيڊ. Zenodo. https://doi.org/10.5281/zenodo.18262555. ResearchGate: https://www.researchgate.net/. Academia.edu: https://www.academia.edu/.. Kantesti AI Medical Research.
ڪلين، ٽي.، مچل، ايس.، ۽ ويبر، ايڇ. (2026). ڪلين، ٽي. (2026). سيرم پروٽين گائيڊ: گلوبلينز، البومين ۽ A/G ريشو بلڊ ٽيسٽ. Zenodo. https://doi.org/10.5281/zenodo.18316300. ResearchGate: https://www.researchgate.net/. Academia.edu: https://www.academia.edu/.. Kantesti AI Medical Research.
📖 ٻاهرين طبي حوالا
سنڊاوس RA et al. (2016). بالغن ۾ الفا-1 اينٽيٽرپسن جي کوٽ جي تشخيص ۽ انتظام. جرنل آف دي COPD فائونڊيشن.
آمريڪي ٿوراسڪ سوسائٽي/يورپي ريسپيريٽري سوسائٽي (2003). الفا-1 اينٽيٽرپسن جي کوٽ سان متاثر ماڻهن جي تشخيص ۽ انتظام لاءِ معيار. آمريڪي جرنل آف ريسپيريٽري اينڊ ڪرٽيڪل ڪيئر ميڊيسن.
اسٽرناڊ P et al. (2020). الفا1-اينٽيٽرپسن جي کوٽ. The Lancet.
پڙهڻ جاري رکو
وڌيڪ طبي رهنمائي، هتان ڪينٽيسٽي طبي ٽيم:

دمہ جون علامتون: شروعاتي اشارا، محرڪ ۽ تشخيص
ڄاڻو ته دمہ جي ڪهڙين علامتن لاءِ فوري طبي امداد ضروري آهي، کنگهه بنا ساهه ۾ سيٽيءَ جي آواز جي ڇو ٿي سگهي ٿي، ۽ اسپائروميٽري ۽ پيڪ فلو ٽيسٽ ڪيئن مدد ڪن ٿا.…
مضمون پڙهو →
فرڪٽوز جي جذب ۾ خرابيءَ جو ٽيسٽ: ساهه جا نتيجا ۽ حدون
فروڪٽوز جي جذب جي خرابيءَ جو ٽيسٽ ساهه جي گيسن کي ماپي ٿو—صرف ميون جي برداشت کي نه. تياري، مثبت نتيجن ۽ مخصوص غذائي آزمائش ڪڏهن…
مضمون پڙهو →
گريوز جي اکين جي بيماريءَ جون علامتون: اکين جي تڪليف جي هنگامي صورتحال لاءِ رهنمائي
ڄاڻو ته گريوز اکين جي بيماريءَ جي ڪهڙين علامتن لاءِ فوري اکين جي سنڀال ضروري آهي، عام ٿائيرائيڊ سطحون ان کي ڇو رد نٿيون ڪن، ۽ ڇا…
مضمون پڙهو →
اڪروميگالي جون علامتون: هٿن، پيرن ۽ چهري جي شڪل ۾ تبديليون
انگوٺي يا جوتي جي سائيز ۾ واڌ، ڄاڙيءَ ۾ تبديليون، گهڻو پگهر اچڻ ۽ ننڊ دوران ساهه بند ٿيڻ ايڪرو ميگاليءَ ڏانهن اشارو ڪري سگهن ٿا. ڄاڻو ته ڪهڙين علامتي نمونن جو جائزو وٺڻ ضروري آهي ۽…
مضمون پڙهو →
ڊيپ وين ٿرومبوسس جون علامتون: ٽنگ ۾ سوڄ جون تڪڙي نشانيون
هڪ ڄنگهه جو سُڄيل ۽ سور وارو هجڻ DVT جي نشاني ٿي سگهي ٿو. ڄاڻو ته ڪهڙين علامتن لاءِ ساڳئي ڏينهن جائزو ضروري آهي، رت جا لٿڙا ڳولڻ جون جاچون ڪيئن ڪم ڪن ٿيون، ۽ سينه…
مضمون پڙهو →
شيزوفرينيا جون علامتون: شروعاتي تبديليون ۽ مدد ڪڏهن وٺجي
شيزوفرينيا جي علامتن کي سڃاڻو، سمجهو ته شروعاتي تبديليون تشخيص ڇو ناهن، ۽ ڄاڻو ته ڪڏهن تڪڙي مدد وٺجي يا بندوبست ڪجي…
مضمون پڙهو →اسان جون سڀ صحت جون رهنمائي ۽ AI-powered خون جي جاچ تجزيو جا اوزار تي ڪانٽيسٽي نيٽ
⚕️ طبي دستبرداري
هي آرٽيڪل صرف تعليمي مقصدن لاءِ آهي ۽ طبي مشورو نٿو بڻجي. تشخيص ۽ علاج جي فيصلن لاءِ هميشه ڪنهن قابل صحت فراهم ڪندڙ سان صلاح ڪريو.
E-E-A-T اعتماد جا سگنل
تجربو
ڊاڪٽر جي نگرانيءَ هيٺ ليبارٽري نتيجن جي تشريح واري عمل جو جائزو.
ماهر
ليبارٽري دوائن جو ڌيان ان ڳالهه تي ته بايو مارڪرز ڪلينڪل حوالي سان ڪيئن رويو ڏيکارين ٿا.
اختيار
ڊاڪٽر ٿامس ڪلين لکيو، ۽ ڊاڪٽر ساره مچل ۽ پروف. ڊاڪٽر هانس ويبر طرفان جائزو ورتل.
اعتبار
ثبوتن تي ٻڌل تشريح، جنهن سان خبرداري گهٽائڻ لاءِ واضح پيرويءَ جا رستا موجود هجن.